Literature DB >> 2785214

Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell cultures of Echinacea purpurea.

B Luettig1, C Steinmüller, G E Gifford, H Wagner, M L Lohmann-Matthes.   

Abstract

In this study, acidic arabinogalactan, a highly purified polysaccharide from plant cell cultures of Echinacea purpurea, with a molecular weight of 75,000, was effective in activating macrophages to cytotoxicity against tumor cells and micro-organisms (Leishmania enriettii). Furthermore, this polysaccharide induced macrophages to produce tumor necrosis factor (TNF-alpha), interleukin-1 (IL-1), and interferon-beta 2. Arabinogalactan did not activate B cells and did not induce T cells to produce interleukin-2, interferon-beta 2, or interferon-gamma, but it did induce a slight increase in T-cell proliferation. When injected ip, this agent stimulated macrophages, a finding that may have therapeutic implications in the defense against tumors and infectious diseases.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2785214     DOI: 10.1093/jnci/81.9.669

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  38 in total

Review 1.  A strategic call to utilize Echinacea-garlic in flu-cold seasons.

Authors:  T Abdullah
Journal:  J Natl Med Assoc       Date:  2000-01       Impact factor: 1.798

2.  Herb-drug interaction between Echinacea purpurea and darunavir-ritonavir in HIV-infected patients.

Authors:  José Moltó; Marta Valle; Cristina Miranda; Samandhy Cedeño; Eugenia Negredo; Manuel José Barbanoj; Bonaventura Clotet
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

3.  Metabolomic analysis reveals that the accumulation of specific secondary metabolites in Echinacea angustifolia cells cultured in vitro can be controlled by light.

Authors:  Chiara Francesca Guarnerio; Marica Fraccaroli; Irene Gonzo; Giovanna Pressi; Roberto Dal Toso; Flavia Guzzo; Marisa Levi
Journal:  Plant Cell Rep       Date:  2011-10-19       Impact factor: 4.570

4.  Antimonial therapy induces circulating proinflammatory cytokines in patients with cutaneous leishmaniasis.

Authors:  Abdurrahim Kocyigit; Selahaddin Gur; Mehmet S Gurel; Vedat Bulut; Mustafa Ulukanligil
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

5.  Evaluation of immunopathologic effects of aqueous extract of Echinacea purpurea in mice after experimental challenge with Pasteurella multocida serotype A.

Authors:  A Rezaie; D Gharibi; M Ghorbanpoor; S Anbari; M Pourmahdi Broojeni
Journal:  Iran J Vet Res       Date:  2014       Impact factor: 1.376

6.  Induction of tumor necrosis factor expression by a lectin from Viscum album.

Authors:  D N Männel; H Becker; A Gundt; A Kist; H Franz
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

7.  Echinacea purpurea (L.) Moench modulates human T-cell cytokine response.

Authors:  Fabiana N Fonseca; Genovefa Papanicolaou; Hong Lin; Clara B S Lau; Edward J Kennelly; Barrie R Cassileth; Susanna Cunningham-Rundles
Journal:  Int Immunopharmacol       Date:  2014-01-13       Impact factor: 4.932

8.  Proprietary arabinogalactan extract increases antibody response to the pneumonia vaccine: a randomized, double-blind, placebo-controlled, pilot study in healthy volunteers.

Authors:  Jay K Udani; Betsy B Singh; Marilyn L Barrett; Vijay J Singh
Journal:  Nutr J       Date:  2010-08-26       Impact factor: 3.271

9.  Potential of Complementary and Alternative Medicine in Preventive Management of Novel H1N1 Flu (Swine Flu) Pandemic: Thwarting Potential Disasters in the Bud.

Authors:  Rajesh Arora; R Chawla; Rohit Marwah; P Arora; R K Sharma; Vinod Kaushik; R Goel; A Kaur; M Silambarasan; R P Tripathi; J R Bhardwaj
Journal:  Evid Based Complement Alternat Med       Date:  2010-10-13       Impact factor: 2.629

10.  Mechanism of stimulation of human natural killer cytotoxicity by arabinogalactan from Larix occidentalis.

Authors:  J Hauer; F A Anderer
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.